Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
The DOI matches its Crossref record; 298 of the 300 references it cites were found in a registry or an index.
Abstract
Abbreviations: A1C = hemoglobin A1C; AACE = American Association of Clinical Endocrinologists; ABCD = adiposity-based chronic disease; ACCORD = Action to Control Cardiovascular Risk in Diabetes; ACCORD BP = Action to Control Cardiovascular Risk in Diabetes Blood Pressure; ACE = American College of Endocrinology; ACEI = angiotensin-converting enzyme inhibitor; AGI = alpha-glucosidase inhibitor; apo B = apolipoprotein B; ARB = angiotensin II receptor blocker; ASCVD = atherosclerotic cardiovascular disease; BAS = bile acid sequestrant; BMI = body mass index; BP = blood pressure; CCB = calcium channel blocker; CGM = continuous glucose monitoring; CHD = coronary heart disease; CKD = chronic kidney disease; DKA = diabetic ketoacidosis; DPP4 = dipeptidyl peptidase 4; eGFR = estimated glomerular filtration rate; EPA = eicosapentaenoic acid; ER = extended release; FDA = Food and Drug Administration; GLP1 = glucagon-like peptide 1; HDL-C = high-density-lipoprotein cholesterol; HeFH = heterozygous familial hypercholesterolemia; LDL-C = low-density-lipoprotein cholesterol; LDL-P = low-density-lipoprotein particle; Look AHEAD = Look Action for Health in Diabetes; NPH = neutral protamine Hagedorn; OSA = obstructive sleep apnea; PCSK9 = proprotein convertase subtilisin-kexin type 9 serine protease; RCT = randomized controlled trial; SU = sulfonylurea; SGLT2 = sodium-glucose cotransporter 2; SMBG = self-monitoring of blood glucose; T2D = type 2 diabetes; TZD = thiazolidinedione.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiologic evidence shows a continuous relationship between A1C and CVD and all-cause mortality.72”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [72]
Citations
Cites
Items 201–298 of 298
Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P., & Braunwald, E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.080 · Cited by 236
Recent advances in physiological lipoprotein metabolism
Ramasamy, I. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0358 · Cited by 235
Sun, F., Wu, S., Wang, J., Guo, S., Chai, S., Yang, Z., Li, L., Zhang, Y., Ji, L., & Zhan, S. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.11.008 · Cited by 232
Consistency With the DASH Diet and Incidence of Heart Failure
Levitan, E. B., Wolk, A., & Mittleman, M. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.56 · Cited by 227
Canner, P. L., Furberg, C. D., Terrin, M. L., & McGovern, M. E. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.013 · Cited by 226
Meneghini, L., Atkin, S. L., Gough, S. C. L., Raz, I., Blonde, L., Shestakova, M., Bain, S., Johansen, T., Begtrup, K., Birkeland, K. I., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1668 · Cited by 226
Self-citationBays, H., Gaudet, D., Weiss, R., Ruiz, J. L., Watts, G. F., Gouni-Berthold, I., Robinson, J., Zhao, J., Hanotin, C., & Donahue, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1520 · Cited by 221
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., Davidson, M. B., Einhorn, D., Garvey, W. T., et al. (2013) · Endocrine Practice · doi:10.4158/ep13176.csuppl · Cited by 220
Self-citationCritical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Rosak, C., & Mertes (2012) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s28340 · Cited by 216
Garvey, W. T., Ryan, D. H., Henry, R., Bohannon, N. J. V., Toplak, H., Schwiers, M., Troupin, B., & Day, W. W. (2014) · Diabetes Care · doi:10.2337/dc13-1518 · Cited by 215
Self-citationGaziano, J. M., Cincotta, A. H., O'Connor, C. M., Ezrokhi, M., Rutty, D., Ma, Z. J., & Scranton, R. E. (2010) · Diabetes Care · doi:10.2337/dc09-2009 · Cited by 213
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
Monami, M., Marchionni, N., & Mannucci, E. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.007 · Cited by 211
Abstract #100: Acth-Secreting Pheochromocytoma
Kalia-Reynolds, M., Giordano, J., Kalia-Reynolds, I., & Houston, C. (2015) · Endocrine Practice · doi:10.1016/s1530-891x(20)42300-6 · Cited by 208
The cardiovascular safety of diabetes drugs–insights from the rosiglitazone experience
Hiatt, W. R., Kaul, S., & Smith, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1309610 · Cited by 204
Metz, J. A., Stern, J. S., Kris-Etherton, P., Reusser, M. E., Morris, C. D., Hatton, D. C., Oparil, S., Haynes, R. B., Resnick, L. M., Pi-Sunyer, F. X., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2150 · Cited by 196
Bruckert, E., Labreuche, J., Deplanque, D., Touboul, P.-J., & Amarenco, P. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318202709f · Cited by 192
Deacon, C. F., Mannucci, E., & Ahrén, B. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01603.x · Cited by 190
Harkness, E., Macdonald, W., Valderas, J., Coventry, P., Gask, L., & Bower, P. (2010) · Diabetes Care · doi:10.2337/dc09-1519 · Cited by 188
Hansen, D., Dendale, P., Jonkers, R. A. M., Beelen, M., Manders, R. J. F., Corluy, L., Mullens, A., Berger, J., Meeusen, R., & van Loon, L. J. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1354-3 · Cited by 185
The Current State of Niacin in Cardiovascular Disease Prevention
Lavigne, P. M., & Karas, R. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.030 · Cited by 185
Adjust to Target in Type 2 Diabetes
Bergenstal, R. M., Johnson, M., Powers, M. A., Wynne, A., Vlajnic, A., Hollander, P., & Rendell, M. (2008) · Diabetes Care · doi:10.2337/dc07-2137 · Cited by 181
Low-Intensity Exercise Reduces the Prevalence of Hyperglycemia in Type 2 Diabetes
MANDERS, R. J. F., VAN DIJK, J.-W. M., & VAN LOON, L. J. C. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b3b16d · Cited by 180
Hutton, B., & Fergusson, D. A. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1461 · Cited by 169
Barnett, A. H., Charbonnel, B., Donovan, M., & Fleming, D. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.665046 · Cited by 162
Mechanick, J. I., Garber, A. J., Handelsman, Y., Garvey, W. T., Beir, D. M., Bohannon, N. J. V., Bray, G. A., Bush, M. A., Evans, J. G., Hurley, D. L., et al. (2012) · Endocrine Practice · doi:10.4158/ep12160.ps · Cited by 160
Self-citationDeVries, J. H., Bain, S. C., Rodbard, H. W., Seufert, J., D’Alessio, D., Thomsen, A. B., Zychma, M., Rosenstock, J., & on behalf of the Liraglutide-Detemir Study Group (2012) · Diabetes Care · doi:10.2337/dc11-1928 · Cited by 159
Winkelman, J. W., Redline, S., Baldwin, C. M., Resnick, H. E., Newman, A. B., & Gottlieb, D. J. (2009) · Sleep · doi:10.1093/sleep/32.6.772 · Cited by 154
González-Campoy, J. M., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Jeor, S. T. S., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.gl · Cited by 154
Self-citationHeise, T., Hövelmann, U., Nosek, L., Hermanski, L., Bøttcher, S. G., & Haahr, H. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1058779 · Cited by 152
Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients
Valencia‐Flores, M., Orea, A., Castaño, V. A., Resendiz, M., Rosales, M., Rebollar, V., Santiago, V., Gallegos, J., Campos, R. M., González, J., et al. (2000) · Obesity Research · doi:10.1038/oby.2000.31 · Cited by 152
Gough, S. C. L., Bhargava, A., Jain, R., Mersebach, H., Rasmussen, S., & Bergenstal, R. M. (2013) · Diabetes Care · doi:10.2337/dc12-2329 · Cited by 150
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release
Garvey, W. T., Ryan, D. H., Bohannon, N. J. V., Kushner, R. F., Rueger, M., Dvorak, R. V., & Troupin, B. (2014) · Diabetes Care · doi:10.2337/dc14-0930 · Cited by 149
Self-citationBailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 149
Self-citationPioglitazone and risk of bladder cancer: a meta‐analysis of controlled studies
Ferwana, M., Firwana, B., Hasan, R., Al‐Mallah, M. H., Kim, S., Montori, V. M., & Murad, M. H. (2013) · Diabetic Medicine · doi:10.1111/dme.12144 · Cited by 146
Pahor, M., Psaty, B. M., Alderman, M. H., Applegate, W. B., Williamson, J. D., & Furberg, C. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.888 · Cited by 146
Inadequate Sleep as a Contributor to Obesity and Type 2 Diabetes
McNeil, J., Doucet, É., & Chaput, J. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.060 · Cited by 144
Sbrocco, T., Nedegaard, R. C., Stone, J. M., & Lewis, E. L. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.67.2.260 · Cited by 142
Death during intensive glycemic therapy of diabetes: mechanisms and implications
Cryer, P. E. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.08.008 · Cited by 137
Lankisch, M. R., Ferlinz, K. C., Leahy, J. L., Scherbaum, W. A., & Orals Plus Apidra and LANTUS (OPAL) study group (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00967.x · Cited by 133
Hypoglycemia in Type 2 Diabetes - More Common Than You Think: A Continuous Glucose Monitoring Study
Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815581052 · Cited by 131
Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
Fonseca, V. A., Handelsman, Y., & Staels, B. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01181.x · Cited by 130
Self-citationMcBrien, K., Rabi, D. M., Campbell, N., Barnieh, L., Clement, F., Hemmelgarn, B. R., Tonelli, M., Leiter, L. A., Klarenbach, S. W., & Manns, B. J. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3147 · Cited by 129
Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125
Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
Viscoli, C. M., Inzucchi, S. E., Young, L. H., Insogna, K. L., Conwit, R., Furie, K. L., Gorman, M., Kelly, M. A., Lovejoy, A. M., Kernan, W. N., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3237 · Cited by 124
Åhrén, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.003 · Cited by 123
Sniderman, A. D. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.12.006 · Cited by 118
Medical Therapy for the Patient With Obesity
Bray, G. A., & Ryan, D. H. (2012) · Circulation · doi:10.1161/circulationaha.111.026567 · Cited by 117
Costanzo, S., Castelnuovo, A. F. D., Donati, M. B., Iacoviello, L., & de Gaetano, G. (2010) · Circulation · doi:10.1161/circulationaha.109.865840 · Cited by 112
Relationship Between Vitamin B 12 and Sensory and Motor Peripheral Nerve Function in Older Adults
Leishear, K., Boudreau, R. M., Studenski, S. A., Ferrucci, L., Rosano, C., de Rekeneire, N., Houston, D. K., Kritchevsky, S. B., Schwartz, A. V., Vinik, A. I., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03998.x · Cited by 112
Ahmed, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl220 · Cited by 110
Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients
Singh, A., Kumar, A., Karmakar, D., & Jha, R. (2013) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.123143 · Cited by 105
Mechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 104
Self-citationGonzález-Campoy, J. M., Jeor, S. T. S., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.esgl · Cited by 103
Self-citationOwens, D. R., Luzio, S. D., Sert‐Langeron, C., & Riddle, M. C. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01459.x · Cited by 99
Home, P. D., Fritsche, A., Schinzel, S., & Massi‐Benedetti, M. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01232.x · Cited by 96
Gaziano, J. M., Cincotta, A. H., Vinik, A., Blonde, L., Bohannon, N., & Scranton, R. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002279 · Cited by 93
Self-citationFalls Risk in Older Adults with Type 2 Diabetes
Vinik, A. I., Vinik, E. J., Colberg, S. R., & Morrison, S. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.09.002 · Cited by 87
Athyros, V. G., Papageorgiou, A. A., Symeonidis, A. N., Didangelos, T. P., Pehlivanidis, A. N., Bouloukos, V. I., & Mikhailidis, D. P. (2003) · Angiology · doi:10.1177/000331970305400607 · Cited by 85
Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes
PRAET, S. F., MANDERS, R. J., LIEVERSE, A. G., KUIPERS, H., STEHOUWER, C. D., KEIZER, H. A., & VAN LOON, L. J. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000235352.09061.1d · Cited by 85
Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia
Christian, J. B., Arondekar, B. V., Buysman, E. K., Jacobson, T. A., Snipes, R., & Horwitz, R. I. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.09.018 · Cited by 85
Forst, T., Hanefeld, M., Jacob, S., Moeser, G., Schwenk, G., Pfützner, A., & Haupt, A. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112465442 · Cited by 85
Garvey, W. T. (2013) · Endocrine Practice · doi:10.4158/ep13263.ra · Cited by 84
Self-citationHuman Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option
Lipska, K. J., Hirsch, I. B., & Riddle, M. C. (2017) · JAMA · doi:10.1001/jama.2017.6939 · Cited by 84
Self-citationEzetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
Masuda, D., Nakagawa‐Toyama, Y., Nakatani, K., Inagaki, M., Tsubakio‐Yamamoto, K., Sandoval, J. C., Ohama, T., Nishida, M., Ishigami, M., & Yamashita, S. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02163.x · Cited by 83
Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
Handelsman, Y. (2011) · Diabetes Care · doi:10.2337/dc11-s237 · Cited by 81
Self-citationDavies, M., Chatterjee, S., & Khunti, K. (2016) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s82008 · Cited by 75
The Approach to the Management of the Patient with Neuropathic Pain
Vinik, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0892 · Cited by 74
Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes
Pan, J., Lin, M., Kesala, R. L., Van, J., & Charles, M. A. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00205.x · Cited by 66
Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
Toth, P. P., Grabner, M., Punekar, R. S., Quimbo, R. A., Cziraky, M. J., & Jacobson, T. A. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.914 · Cited by 62
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
An evaluation of a television-delivered behavioral weight loss program: Are the ratings acceptable?
Meyers, A. W., Graves, T. J., Whelan, J. P., & Barclay, D. R. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.1.172 · Cited by 52
Common Standards of Basal Insulin Titration in T2DM
Arnolds, S., Heise, T., Flacke, F., & Sieber, J. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700323 · Cited by 52
De Feyter, H. M., Praet, S. F., van den Broek, N. M., Kuipers, H., Stehouwer, C. D., Nicolay, K., Prompers, J. J., & van Loon, L. J. C. (2007) · Diabetes Care · doi:10.2337/dc07-0183 · Cited by 51
Leech, C. A., Dzhura, I., Chepurny, O. G., Schwede, F., Genieser, H.-G., & Holz, G. G. (2010) · Islets · doi:10.4161/isl.2.2.10582 · Cited by 50
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
McGill, J. B., & Ahmann, A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0090 · Cited by 49
Self-citationRosenstock, J., Rodbard, H. W., Bain, S. C., D’Alessio, D., Seufert, J., Thomsen, A. B., Svendsen, C. B., & DeVries, J. H. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.008 · Cited by 46
Lipid management: Current diet and drug treatment options
Stone, N. J. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00319-1 · Cited by 44
PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemia
Verbeek, R., Stoekenbroek, R. M., & Hovingh, G. K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.099 · Cited by 44
Insulin Therapy in Type 2 Diabetes Mellitus
Leahy, J. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.004 · Cited by 43
for the Diabetes Prevention Program Research Group, Hoskin, M. A., Bray, G. A., Hattaway, K., Khare-Ranade, P. A., Pomeroy, J., Semler, L. N., Weinzierl, V. A., & Wylie-Rosett, J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0094-2 · Cited by 40
An evaluation of a television-delivered behavioral weight loss program: Are the ratings acceptable?
Meyers, A. W., Graves, T. J., Whelan, J., et al. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.1.172 · Cited by 40
Hypoglycemia: Minimizing its impact in type 2 diabetes
Moghissi, E., Ismail-Beigi, F., & Devine, R. C. (2013) · Endocrine Practice · doi:10.4158/ep13005.ra · Cited by 39
Blackberry, I., Furler, J., Ginnivan, L., Manski-Nankervis, J.-A. E., Jenkins, A. J., Cohen, N. D., Best, J. D., Young, D. Y. L., Liew, D., Ward, G. M., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.011 · Cited by 38
Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes
Rosenson, R. S., Abby, S. L., & Jones, M. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.026 · Cited by 34
Balducci, S., Alessi, E., Cardelli, P., Cavallo, S., Fallucca, F., & Pugliese, G. (2007) · Diabetes Care · doi:10.2337/dc06-2495 · Cited by 33
Davies, M., Sasaki, T., Gross, J. L., Bantwal, G., Ono, Y., Nishida, T., Tojjar, D., & Seino, H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12573 · Cited by 33
Mechanick, J. I., Adams, S., Davidson, J. A., Fergus, I. V., Galindo, R. J., McKinney, K. H., Petak, S. M., Sadhu, A. R., Samson, S. L., Vedanthan, R., et al. (2019) · Endocrine Practice · doi:10.4158/ps-2019-0080 · Cited by 33
Self-citationEfficacy of colesevelam on lowering glycemia and lipids
Aggarwal, S., Loomba, R. S., & Arora, R. R. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31823a109f · Cited by 30
Peyrot, M., Rubin, R. R., Polonsky, W. H., & Jennie Best, H. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003634759 · Cited by 27
SGLT2 inhibitors and diabetic ketoacidosis — a growing concern
Umpierrez, G. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.77 · Cited by 27
Self-citationFuller, P. R., Perri, M. G., Leermakers, E. A., & Guyer, L. K. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(97)00016-6 · Cited by 26
Meal Replacements for Weight Loss in Type 2 Diabetes in a Community Setting
Keogh, J. B., & Clifton, P. M. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/918571 · Cited by 23
Grunberger, G., Bailey, T. S., Camacho, P. M., EINHORN, D. F., Garber, A. J., Handelsman, Y., Harrell, R. M., Lando, H. M., Law, B., Leffert, J. D., et al. (2015) · Endocrine Practice · doi:10.4158/ep15653.cs · Cited by 22
Self-citationTunis, S. L., Sauriol, L., & Minshall, M. E. (2010) · Applied Health Economics and Health Policy · doi:10.2165/11535380-000000000-00000 · Cited by 21
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
McGill, J. B., Ahn, D. T., Edelman, S. V., Kilpatrick, C. R., & Cavaiola, T. S. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0370-1 · Cited by 18
Self-citationBloomgarden, Z. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12065 · Cited by 13
(2011) · Diabetes Care · doi:10.2337/dc11-er06 · Cited by 12
Chowta, M. N., & Tiwary, G. (2014) · Journal of Postgraduate Medicine · doi:10.4103/jpgm_20146001_96 · Cited by 8
Cited by
McGuire, D. K., Shih, W. J., Cosentino, F., Charbonnel, B., Cherney, D. Z. I., Dagogo-Jack, S., Pratley, R., Greenberg, M., Wang, S., Huyck, S., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.4511 · Cited by 1,235
Trends in diabetes treatment and control in U.S. adults, 1999-2018
Fang, M., Wang, D., Coresh, J., & Selvin, E. (2021) · New England Journal of Medicine · doi:10.1056/nejmsa2032271 · Cited by 690
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationSamson, S. L., Vellanki, P., Blonde, L., Christofides, E. A., Galindo, R. J., Hirsch, I. B., Isaacs, S. D., Izuora, K. E., Low Wang, C. C., Twining, C. L., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.02.001 · Cited by 375
Self-citationGLP-1 receptor agonists: an updated review of head-to-head clinical studies
Trujillo, J. M., Nuffer, W., & Smith, B. A. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821997320 · Cited by 289
“0 mg QW 60/299 (20) 29/299 (10) 53/299 (18) 8/299 (3) 20”
Metadata
- Authors
- Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., Garvey, W. T., Hirsch, I. B., Jellinger, P. S., McGill, J. B., Mechanick, J. I., Perreault, L., Rosenblit, P. D., Samson, S., & Umpierrez, G. E.
- Affiliations
- Baylor College of Medicine (US)
- Oakland University (US)
- University of California San Diego (US)
- Beth Israel Deaconess Medical Center (US)
- Kaiser Permanente (US)
- Ochsner Health System (US)
- Cedars-Sinai Medical Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- University of Miami (US)
- Washington University in St. Louis (US)
- Icahn School of Medicine at Mount Sinai (US)
- University of Colorado Anschutz (US)
- University of California, Irvine (US)
- Emory University (US)
- ORCID
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 26
- Issue
- 1
- Pages
- 107-139
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W3004838676
- Cited by
- 598
- References
- 300
- Citations by year
- 2026: 21 · 2025: 41 · 2024: 80 · 2023: 104 · 2022: 146 · 2021: 125 · 2020: 81
- FWCI
- 85.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes management, glycemic control, cardiovascular risk, atherosclerotic cardiovascular disease, chronic kidney disease, diabetic ketoacidosis, obstructive sleep apnea, dyslipidemia, obesity, GLP-1 receptor agonists, SGLT2 inhibitors, insulin therapy, continuous glucose monitoring, self-monitoring of blood glucose
- MeSH terms
- Proprotein Convertase 9, Endocrinologists, Algorithms, Blood Glucose, Diabetes Mellitus, Type 2, Humans, United States, Blood Glucose Self-Monitoring, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.